Kristina Gemzell‐Danielsson

ORCID: 0000-0001-6516-1444 · 47 papers in corpus · active 1993-2025

Study types

  • article 32
  • review 5
  • preprint 4
  • other 2
  • editorial 1

Condition tags

  • endometriosis 29
  • adenomyosis 12
  • infertility 7
  • dysmenorrhea 5
  • endometrioma 4
  • dyspareunia 1
article 2025
Human Reproduction ·doi:10.1093/humrep/deaf101

STUDY QUESTION: Is childhood adversity associated with the subsequent diagnosis of endometriosis? SUMMARY ANSWER: Childhood adversities, including parental substance abuse, parental intellectual disability, parental psychiatric disorder, h…

preprint 2025
·doi:10.20944/preprints202501.0736.v1

Background/Objectives: Endometriosis has a marked impact on fertility, although the mechanisms behind this relationship remain poorly understood, particularly in cases without significant anatomical distortions or in the context of ovarian …

article 2025
Biomedicines ·doi:10.3390/biomedicines13020348

Background/Objectives: Endometriosis has a marked impact on fertility, although the mechanisms behind this relationship remain poorly understood, particularly in cases without significant anatomical distortions or in the context of ovarian …

preprint 2024
·doi:10.1101/2024.02.27.580606

Abstract Current therapeutics of endometriosis are limited to hormonal action on endometriotic lesions to disrupt their growth. Based on the recent findings of the high utilization of glycolysis over oxidative metabolism (Warburg-like effec…

other 2024
Communications biology ·doi:10.1038/s42003-024-06713-5

Current therapeutics of endometriosis focus on hormonal disruption of endometriotic lesions (ectopic endometrium, EcE). Recent findings show higher glycolysis utilization in EcE, suggesting non-hormonal strategy for disease treatment that a…

review 2024
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception ·doi:10.1080/13625187.2024.2317295

PURPOSE: This review presents an update of the non-contraceptive health benefits of the combined oral contraceptive pill. METHODS: We conducted a literature search for (review) articles that discussed the health benefits of combined oral c…

other 2024
Biomolecules ·doi:10.3390/biom14111400

(1) Background: Endometriosis is a highly prevalent gynecological disease affecting 10% of women of reproductive age worldwide. miRNAs may play a role in endometriosis, though their exact function remains unclear. This study aimed to identi…

article 2023
·doi:10.3390/endocrines4040048

Infertility caused by a thin endometrium remains a significant challenge in assisted reproduction and is often associated with a low success rate after treatment with assisted reproductive technology. There is a lack of consensus in the fie…

article 2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1026168

OBJECTIVE: Bromocriptine treatment has been shown to reduce menstrual bleeding and pain in women with adenomyosis in a pilot clinical trial. The underlying mechanism contributing to the treatment effect is however unknown. The purpose of th…

preprint 2023
·doi:10.20944/preprints202306.0024.v1

Our aim was to compare the inter-rater agreement of Transvaginal ultrasonography (TVS) with Magnetic Resonance Imaging (MRI) regarding diagnosing adenomyosis and for various predefined imaging features of adenomyosis in the same set of wome…

article 2023
Diagnostics ·doi:10.3390/diagnostics13132193

Our aim was to compare the inter-rater agreement about transvaginal ultrasonography (TVS) with magnetic resonance imaging (MRI) with regard to diagnosing adenomyosis and for assessing various predefined imaging features of adenomyosis, in t…

rct 2023
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.14662

INTRODUCTION: Intrauterine devices (IUDs) effectively prevent unwanted pregnancies. Little is known about long-term outcomes of women choosing an IUD after early medical abortion. MATERIAL AND METHODS: We present secondary outcome data of …

article 2023
·doi:10.1093/humrep/dead093.704

Abstract Study question What is the role of dysregulated endometrial microRNAs (miRNAs) in the development of endometriosis? Summary answer Dysregulated miRNAs in the endometrium of women with endometriosis can also be found in endometrioma…

article 2023
·doi:10.1097/01.ogx.0000912608.55729.b1

(Abstracted from Eur J Obstet Gynecol Reprod Biol 2020;254:38–43) Adenomyosis is a common, benign uterine disease that causes heavy menstrual bleeding and pelvic pain. A diagnosis of adenomyosis traditionally required hysterectomy, but now …

article 2022
·doi:10.1093/humrep/deac105.103

Abstract Study question Is once-daily linzagolix treatment for women with moderate to severe endometriosis-associated pain (EAP) safe for use for up to 6 months of treatment? Summary answer Both doses of linzagolix were well-tolerated with …

article 2021
Journal of personalized medicine ·doi:10.3390/jpm11060448

The endometrium undergoes regular regeneration and stromal proliferation as part of the normal menstrual cycle. To better understand cellular interactions driving the mechanisms in endometrial regeneration we employed single-cell RNA sequen…

article 2020
·doi:10.1016/j.ejogrb.2020.06.056
preprint 2020
·doi:10.1101/2020.07.17.203844

Abstract The endometrium undergoes regular regeneration and stromal proliferation as part of the normal menstrual cycle. To better understand cellular interactions driving the mechanisms in endometrial regeneration we employed single-cell R…

article 2020
Human Reproduction ·doi:10.1093/humrep/deaa164

STUDY QUESTION: What is the physiological role of transforming growth factor-beta (TGF-β1) and syndecans (SDC1, SDC4) in endometriotic cells in women with endometriosis? SUMMARY ANSWER: We observed an abnormal, pro-invasive phenotype in a s…

article 2020
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2020.08.040
article 2020
·doi:10.1097/ogx.0000000000000758

(Abstracted from Acta Obstet Gynecol Scand 2019;98:1341–1350) Animal models suggest that increased uterine prolactin concentration is a risk factor for adenomyosis. Prolactin is produced in the human endometrium, myometrium, and the pituita…

article 2019
·doi:10.1136/ijgc-2019-igcs.58
review 2019
·doi:10.1111/aogs.13598

An update on the current state of endometrial cell therapies in terms of cell types, mechanisms of action, delivery, safety, regulatory frameworks and future perspectives. This review focuses on clinical trials using angiogenesis-promoting …

review 2019
Reproductive biomedicine online ·doi:10.1016/j.rbmo.2019.11.003
article 2019
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.13632

INTRODUCTION: Adenomyosis is a benign uterine disease where endometrial glands and stroma are found within the myometrium surrounded by an area of hypertrophic myometrium. Symptomatology includes heavy menstrual bleeding and pelvic pain. Th…